Carol Gregorio

9PUBLICATIONS
37CO-AUTHORS
Cellular interactions (incl. adhesion, matrix, cell wall)Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Gene and molecular therapyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 20, 2026
Leiomodin 2 is a processive pointed-end elongator of actin filaments.

|Apr 24, 2025
Prediction and biological significance of small changes in binding of leiomodin to tropomyosin.

Eduardo Sánchez Díaz, Brayan Osegueda, Svetlana Minakhina

|Sep 16, 2024
Leiomodin 2 neonatal dilated cardiomyopathy mutation results in altered actin gene signatures and cardiomyocyte dysfunction.

Jessika B Iwanski, Christopher T Pappas, Rachel M Mayfield

|May 15, 2024
Human disease-causing mutations result in loss of leiomodin 2 through nonsense-mediated mRNA decay.

Christopher T Pappas, Rachel M Mayfield, Ava E Dickerson

|Mar 13, 2024
Lmod2 is necessary for effective skeletal muscle contraction.

Tania M Larrinaga, Gerrie P Farman, Rachel M Mayfield

|Jan 03, 2024
Recessive TMOD1 mutation causes childhood cardiomyopathy.

Catalina Vasilescu, Mert Colpan, Tiina H Ojala

Pageof 2

Frequent Collaborators

4 joint publications

Christopher T Pappas

3 joint publications

Tania M Larrinaga

2 joint publications

Rebecca C Ahrens-Nicklas

2 joint publications

Rachel M Mayfield